STAAR Surgical (NASDAQ: STAA) and LDR Holding Corp (NASDAQ:LDRH) are both medical equipment, supplies & distribution – nec companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends.
This table compares STAAR Surgical and LDR Holding Corp’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|LDR Holding Corp||-18.02%||-16.37%||-13.65%|
Earnings & Valuation
This table compares STAAR Surgical and LDR Holding Corp’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||NetIncome||Earnings Per Share||Price/Earnings Ratio|
|STAAR Surgical||$82.43 million||6.28||-$12.12 million||($0.13)||-96.92|
|LDR Holding Corp||N/A||N/A||N/A||($0.71)||N/A|
LDR Holding Corp has higher revenue, but lower earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than LDR Holding Corp, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
76.7% of STAAR Surgical shares are owned by institutional investors. 5.6% of STAAR Surgical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
This is a summary of current recommendations and price targets for STAAR Surgical and LDR Holding Corp, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|LDR Holding Corp||0||0||0||0||N/A|
STAAR Surgical currently has a consensus price target of $15.00, suggesting a potential upside of 19.05%.
STAAR Surgical beats LDR Holding Corp on 8 of the 8 factors compared between the two stocks.
About STAAR Surgical
STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery. It makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). As of December 30, 2016, it sold its products in more than 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world.
About LDR Holding Corp
LDR Holding Corporation is a medical device company. The Company focuses on designing and commercializing surgical technologies for the treatment of patients suffering from spine disorders. The Company’s primary products are based on its VerteBRIDGE fusion and Mobi non-fusion platforms, both of which are designed for applications in the cervical and lumbar spine. The Company’s VerteBRIDGE products are designed around its plating technology that enables surgeons to implant VerteBRIDGE devices with direct visualization of the disc and to affix the devices to the vertebrae from inside the spinal disc space. The Company’s Mobi non-fusion platform is underlined by Mobi-C, a cervical disc replacement device with a mobile bearing core that is designed to replicate the natural anatomical movement of the spine by facilitating independent bending and twisting similar to a healthy disc. The Company’s traditional fusion products include Easyspine, MC+, ROI, ROI-T, SpineTune and C-Plate.
What are top analysts saying about STAAR Surgical Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for STAAR Surgical Company and related companies.